CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GES M B H - Austria 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:500-600
Total Number of Projects:900-1000
2019
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:> 1000
Total Number of Projects:600-700

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 15
As coordinator: 2
As participant: 6
Sole participant: 7
Coordinator / Participant Ratio: 0.33*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 183.601 0 1
2021 3.522.414 0 3.164.637 5
2020 6.330.028 18.947.299 2.942.653 2 2
2019 364.324 7.720.643 1.001.336 2 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
MEDIZINISCHE UNIVERSITAET WIEN3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITY OF CAMBRIDGE2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AGILENT TECHNOLOGIES FRANCE1
ASTRAZENECA1
AXXAM1
BAYER1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOCRATES LIFE SCIENCES1
BIOMERIEUX1
BIOTALENTUM TUDASFEJLESZTO KFT1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CERTARA UK LIMITED1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELLINIKO INSTITUTO MELETIS TIS SIPSIS1
ELSEVIER BV1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION1
HOSPICES CIVILS DE LYON1
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE1
INSTITUTO PASTEUR ITALIA FONDAZIONECENCI BOLOGNETTI1
IVI VALENCIA SL1
JANSSEN VACCINES & PREVENTION BV1
LEIDEN UNIVERSITY1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MARIE CURIE ALUMNI ASSOCIATION1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDICAL WOMEN'S INTERNATIONAL ASSOCIATION1
MWM BIOMODELS1
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU1
PFIZER LIMITED1
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV1
RHEINISCHE FRIEDRICH WILHELMS UNIVERSITAET BONN1
SCIPHER MEDICINE CORPORATION1
SICHUAN UNIVERSITY1
SOVALACC BV1
ST ANNA KINDERKREBSFORSCHUNG1
STICHTING HUBRECHT ORGANOID TECHNOLOGY1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM1
STICHTING RADBOUD UNIVERSITEIT1
STIMUNITY SAS1
SZENT ISTVAN EGYETEM1
TEL AVIV UNIVERSITY1
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF MANCHESTER1
UNIVERSITAT DE VALENCIA1
UNIVERSITAT WIEN1
UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJNAPOCA1
UNIVERSITATSKLINIKUM JENA1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF READING1
UNIVERSITY OF SOUTHAMPTON1
VRIJE UNIVERSITEIT BRUSSEL1

Constancy:

Total number of partners: 65
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 62
Frequent / Rare Partner Ratio: 0.05

Project overview:

Start dateProjectacronymrolefundingpartners
2022-11-01High resolution dissection of non-coding determinants of disease B-ALLelesparticipant183.6012
2021-12-01Understanding and exploiting epigenetic regulation in CAR T cell therapy EPI-CARTcoordinator1.999.9131
2021-06-01Add medical genetic solutions to RESOLUTE (REsolution) REsolutioncoordinator1.000.0009
2021-04-01Closing the gap: studying non-obvious ligand induced degradation events MapInDegraderscoordinator174.1671
2021-04-01The impact of hyperammonemia in viral infection pathophysiology AmmoniaVircoordinator174.1671
2021-04-01Tumor targeting through a TME-specific regulatory code and programmable CAR T cells TRAP-CARTcoordinator174.1671
2020-03-01Dna Damage REsponse: Actionabilities, Maps and Mechanisms DDREAMMparticipant8.865.9654
2020-01-01Personalized immunotherapy in sepsis: a precision medicine based approach ImmunoSepparticipant10.081.33415
2020-01-01HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research HCA Organoidcoordinator4.998.6888
2020-01-01Therapeutic hijacking of E3 Ligases Glue2Degradecoordinator1.331.3401
2019-07-01Deep-learning models of CRISPR-engineered cells define a rulebook of cellular transdifferentiation SingleCellAIcoordinator186.1671
2019-07-01Periconceptional Programming of Health Training Network DohART-NETparticipant3.480.36919
2019-05-01INnate-ImmunomeTabolIsm as Antiviral TargEt INITIATEparticipant4.054.10614
2019-05-01Repair of DNA lesions induced by platinum drugs REAPparticipant186.1672
2019-02-15Chemical probing of transcriptional RAS effectors ChemRAScoordinator178.1571

Alias institution names:

  • CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GES M B H